Doxorubicin With Cyclophosphamide Followed by Docetaxel Every 21 Days Compared With Doxorubicin and Docetaxel Every 14 Days As Preoperative Treatment in Operable Breast Cancer: The GEPARDUO Study of the German Breast Group

von Minckwitz, Gϋnter; Raab, G.; Caputo, Angelika; Schütte, Martin; Hilfrich, J.; Blohmer, Jens‐Uwe; Gerber, Bernd; Dan Costa, Serban; Merkle, E.; Eidtmann, Holger; Lampe, Dieter; Jackisch, Christian; du Bois, Andreas; Kaufmann, Manfred

doi:10.1200/jco.2005.05.078

Public

Doxorubicin With Cyclophosphamide Followed by Docetaxel Every 21 Days Compared With Doxorubicin and Docetaxel Every 14 Days As Preoperative Treatment in Operable Breast Cancer: The GEPARDUO Study of the German Breast Group

Published in Journal of Clinical Oncology • Apr 18, 2005

Authors:

Gϋnter von Minckwitz

G. Raab

Angelika Caputo

Abstract

PURPOSE: Dose-dense and sequential administration of cytotoxic drugs are current approaches to improve outcomes in patients with early-stage breast cancer. METHODS: This phase III study investigated 913 women with untreated operable breast cancer (T2-3, N0-2, M0) randomly assigned to receive either ...

Subject

Docetaxel

Medicine

Doxorubicin

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!